On (b)(6) 2018, the lay user/patient contacted lifescan (lfs) usa, alleging an issue with her onetouch ultra test strip vial.The patient claimed that the vial inside a sealed container was open.The complaint was classified based on further information obtained by the medical surveillance specialist after reviewing the call recording since the patient was unable to be contacted by phone for additional information.The patient reported that she became aware of the alleged open vial on (b)(6) 2018 at 8:00 am.The patient informed the csr that she manages her diabetes with a combination of oral medication (metformin) and insulin (humulin).The patient denied making any changes to her usual diabetes management regimen when she was unable to test her blood glucose due to the alleged issue.During the call, the patient reported developing ¿low blood sugar¿ as a result of the alleged issue.The patient claimed she proceeded to the urgent care clinic on (b)(6) 2018 at 10:00 am where her blood glucose was measured at ¿48 mg/dl¿ on the clinic device.During the call, the patient claimed she received unspecified treatment and was reportedly advised to increase her daily dose of metformin medication.At the time of troubleshooting, the customer service representative confirmed the product was being used for the first time.Replacement product was sent to the patient.This complaint is being reported because the patient claims she was unable to test her blood glucose due to the reported issue and reportedly developed signs/symptoms suggestive of a serious injury adverse event after the alleged product issue began.The subject device could not be ruled out as a cause or contributor to the event.
|